
104 new drugs approved in Europe in 2025
In 2025, the European Medicines Agency (EMA) recommended 104 medicines for marketing authorisation, 38 of which had a new active substance which had never been authorised in the European Union (EU) before. These included the first medicine to treat non-cystic fibrosis bronchiectasis, a first-in-class treatment to delay… Read More















